Cardiometabolic disease prevention and treatment guidelines

  • In development GID-HUB10002

This webpage covers all NICE’s guidelines on cardiometabolic disease prevention and treatment The table presents the guidelines alphabetically within their topic area. Updates planned or in progress and areas we’re actively monitoring are listed for each guideline, and there are links to the individual update pages for more information.

Guidelines

Cardiovascular disease

None

Guideline

Updates planned and in progress

Key topic areas we’re proposing to actively monitor

Abdominal aortic aneurysm: diagnosis and management

    

Acute coronary syndromes

-

None

Acute heart failure: diagnosis and management

-

None

Atrial fibrillation: diagnosis and management

-

 

  

Anticoagulation recs 1.6.1-1.6.8

 

Assessing anticoagulation control with vitamin K antagonists and Antiplatelets recs 1.6.9-1.6.13

Cardiovascular disease: identifying and supporting people most at risk of dying early

-

None

Cardiovascular disease prevention

- 

None

Cardiovascular disease: risk assessment and reduction, including lipid modification

Update published

Escalation of therapy

None

Chronic heart failure in adults: diagnosis and management

Update in progress:

Pharmacological treatment

Cardiac MRI in diagnosing heart failure (review Q but no recs)

 

Iron supplementation in people with chronic heart failure and iron deficiency (review Q but no recs)

 

Telemonitoring and self-monitoring in people with heart failure (review Q but no recs)

Familial hypercholesterolaemia: identification and management

- Case finding recs 1.1.1-1.1.16 prioritised at PB in 2024

  Identifying people using cascade testing recs 1.2.1-1.2.4

Heart valve disease presenting in adults: investigation and management

-

Management of heart failure in people with valve disease recs 1.2.1-1.2.2

 

Interventions for mitral regurgitation recs 1.5.8-1.5.14

 

Interventions for tricuspid regurgitation recs 1.5.15-1.5.16

Hypertension in adults: diagnosis and management

-

None

Non-alcoholic fatty liver disease (NAFLD): assessment and management

 Update in progress 

None

Peripheral arterial disease: diagnosis and management

-

None

Recent-onset chest pain of suspected cardiac origin: assessment and diagnosis

-

None

Stable angina: management

- 

None

Stroke and transient ischaemic attack in over 16s: diagnosis and initial management

- 

Suspected TIA recs 1.2.1-1.2.2

 

Urgent carotid endarterectomy recs 1.2.4-1.2.6

Varicose veins: diagnosis and management

-

None

Venous thromboembolic diseases: diagnosis, management and thrombophilia testing

-

None

Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism

-

All patients, and medical patients admitted to hospital recs 1.1.1-1.1.4

 

Surgical and trauma patients recs 1.5.5-.1.5.7

 

Lower limb immobilisation rec 1.11.1

 

Interventions for people with major trauma recs 1.13.1-1.1.13.3

 

Interventions for pregnant women and women who gave birth or had a miscarriage or termination of pregnancy in the past 6 weeks recs 1.16.1-1.16.6

Diabetes

Guideline

Updates planned and in progress

Key topic areas we’re proposing to actively monitor

Diabetes in pregnancy: management from preconception to the postnatal period

-

Diagnosis of gestational diabetes

Preconception planning and care: HbA1c targets

Antenatal care for women with diabetes: blood glucose targets

Preconception planning and care: safety of diabetes medicines before, during and after pregnancy

Blood glucose monitoring from preconception to postnatal period:

Renal assessment during pregnancy

Diabetes (type 1 and type 2) in children and young people: diagnosis and management

-

Education and information: type 1 diabetes

Ketone monitoring

Blood glucose monitoring frequency and techniques: type 1 diabetes

Metformin for type 2 diabetes

Fluid therapy for diabetic ketoacidosis

Diabetic retinopathy: type 1 diabetes and type 2 diabetes

Diabetic foot problems: prevention and management

-

Diabetic foot problems: prevention and management

Type 1 diabetes in adults: diagnosis and management

-

Diagnosis

Education and information

Ketone monitoring

Care during other illness: blood glucose control in hospital

Insulin therapy

Managing complications: diabetic kidney disease, eye disease, gastroparesis, erectile dysfunction

Type 2 diabetes in adults: management

Update in progress:

Dietary advice

Insulin-based therapy

Medicines other than insulin

Diagnosing and managing hypertension

Assessment and treatment of cardiovascular risk factors

Managing complications: chronic kidney disease, eye disease, gastroparesis, erectile dysfunction

Type 2 diabetes: prevention in people at high risk

 -

Risk assessment:

Intensive lifestyle-change programmes:

Medication:

Type 2 diabetes prevention: population and community-level interventions

 -  

Physical activity

Guideline

Updates planned and in progress

Key topic areas we’re proposing to actively monitor

Physical activity and the environment

-

To be confirmed

Physical activity: brief advice for adults in primary care

-

To be confirmed

Physical activity: exercise referral schemes

-

To be confirmed

Physical activity for children and young people

-

To be confirmed

Physical activity in the workplace

-

To be confirmed

Physical activity: walking and cycling

-

To be confirmed

Weight management

Guideline

Updates planned and in progress

Key topic areas we’re proposing to actively monitor
Overweight and obesity management -

To be confirmed

Methods

Areas for active monitoring are identified by our maintaining and updating our guideline portfolio process including validation with stakeholders.

Active monitoring is ongoing surveillance in key topic areas. It involves one or more of:

  • monitoring studies in progress by systematically searching for ongoing studies and assessing the results when published
  • monitoring newly published studies by continuous searching of newly published evidence
  • system monitoring by systematically collating intelligence from the health and care system and working with partners to identify areas of change.

Guideline recommendations are developed using the methods and processes in developing NICE guidelines: the manual and the interim principles for methods and processes for supporting digital living guideline recommendations.

If you have new information, intelligence or evidence relevant to any of the key topic areas listed above, please contact prioritisation@nice.org.uk.